Anavex nominates two directors amid proxy fight with PVG

Go back to Anavex nominates two directors amid proxy fight with PVG

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

August 3, 2026 8:00 AM EDT

Nominates Two New Independent Directors, Mr. Gautam Patel and Dr. Adrian Senderowicz, 
Who Bring Deep, Relevant Experience in Life Sciences

Mr. Patel and Dr. Senderowicz to Stand for Election at 2026 Annual Meeting with Independent Directors
Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger and Dr. Claus van der Velden

Urges Stockholders to Reject Attempt by PVG Asset Management Corporation and Patrick S. Adams to Acquire Control of the Company

Issues Open Letter to Stockholders and Files Preliminary Proxy Statement

NEW YORK,... More